Immune-Related Adverse Events for GI Toxicity - Colitis
Grades severity of colitis secondary to immune checkpoint inhibitor therapy.
INSTRUCTIONS
Use in adult patients with colitis symptoms that developed while on treatment with immune checkpoint inhibitors.
When to Use
Pearls/Pitfalls
Why Use
Increase of <4 stools per day over baseline; mild increase in ostomy output compared with baseline
+1Increase of 4-6 stools per day over baseline; moderate increase in ostomy output compared with baseline
+2Increase of ≥7 stools per day over baseline; incontinence; hospitalization indicated; severe increase in ostomy output compared with baseline; limiting self-care/activities of daily living
+3Life-threatening consequences; urgent intervention indicated
+4Result:
Please fill out required fields.